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The energy requirements of the brain are very high, and tight regulatory mechanisms operate to ensure
adequate spatial and temporal delivery of energy substrates in register with neuronal activity. Astro-
cytes—a type of glial cell—have emerged as active players in brain energy delivery, production, utilization,
and storage. Our understanding of neuroenergetics is rapidly evolving from a ‘‘neurocentric’’ view to
a more integrated picture involving an intense cooperativity between astrocytes and neurons. This review
focuses on the cellular aspects of brain energymetabolism, with a particular emphasis on themetabolic inter-
actions between neurons and astrocytes.Introduction
Glucose is the obligatory energy substrate of the adult brain.
Nevertheless, under particular circumstances the brain has the
capacity to use other blood-derived energy substrates, such
as ketone bodies during development and starvation (Nehlig,
2004; Magistretti, 2008) or lactate during periods of intense
physical activity (van Hall et al., 2009). Glucose enters cells
trough specific glucose transporters (GLUTs) and is phosphory-
lated by hexokinase (HK) to produce glucose-6-phosphate. As in
other organs, glucose 6-phosphate can be processed via
different metabolic pathways (Figure 1A), the main ones being
(1) glycolysis (leading to lactate production or mitochondrial
metabolism), (2) the pentose phosphate pathway (PPP), and (3)
glycogenesis (in astrocytes only, see below). Overall, glucose
is almost entirely oxidized to CO2 and water in the brain (Clarke
and Sokoloff, 1999). Nevertheless, as evidenced by the different
metabolic routes that glucose can follow, each individual brain
cell does not necessarily metabolize glucose to CO2 and water.
Indeed, a wide range of metabolic intermediates formed from
glucose in the brain can subsequently be oxidized for energy
production (e.g., lactate, pyruvate, glutamate, or acetate) (Zielke
et al., 2009).
The brain has high energy requirements. About 20% of the
oxygen and 25% of the glucose consumed by the human body
are dedicated to cerebral functions, yet the brain represents
only 2% of the total body mass. Maintenance and restoration
of ion gradients dissipated by signaling processes such as post-
synaptic and action potentials, as well as uptake and recycling of
neurotransmitters, are the main processes contributing to the
high brain energy needs (Attwell and Laughlin, 2001; Alle et al.,
2009). Among them, synaptic potentials, rather than action
potentials, appear to represent by far the main energetic cost
related tomaintenance of excitability (Alle et al., 2009). Excitatory
synapses largely dominate in the gray matter—glutamatergic
ones alone represent at least 80% of cortical synapses—sug-
gesting that excitatory neurotransmission accounts for most of
the energy requirements at the cortical level. Correspondingly,724 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.it has been estimated that glutamate-mediated neurotransmis-
sion is responsible for most (80%) of the energy expended in
the gray matter (Sibson et al., 1998; Hyder et al., 2006; Shulman
et al., 2004; Attwell and Laughlin, 2001), highlighting the close
relationship between brain activity, glutamatergic neurotrans-
mission, energy requirements, and glucose utilization.
Astriking featureofbrainenergymetabolismis the tight coupling
that exists between energy demand and supply (reflected by
glucose and oxygen delivery from the vasculature). Indeed, task-
dependent increases in cerebral activity are invariably accompa-
nied by changes in local blood flow and glucose utilization—these
processes being referred to as neurovascular and neurometabolic
coupling, respectively (Figures 1B, 2B, and 2C). These close rela-
tionships constitute the basis for functional brain imaging tech-
niques which have enabled ‘‘functional mapping’’ studies in the
brain. Among them, positron emission tomography (PET) allows
determination of the cerebral metabolic rate of glucose consump-
tion (CMRglc), the cerebral metabolic rate of oxygen consumption
(CMRO2), or the cerebral blood flow (CBF), while functional
magnetic resonance imaging (fMRI) mostly measures brain
oxygenation and blood volume (Magistretti and Pellerin, 1996;
Raichle and Mintun, 2006; Figley and Stroman, 2011).
Since neurons account for most of the energy consumption
during brain activation, it was first rationally assumed that
CMRglc measurements from 18F-fluoro-2-deoxyglucose (FDG)-
PET signals directly reflected the neuronal use of glucose (Sokol-
off et al., 1977). In addition, neurometabolism was postulated to
be a strictly oxidative (i.e., oxygen-depending) process—an
assumption based on the higher efficiency to produce ATP
from glucose oxidation in the mitochondria (oxidative process)
compared to glycolysis (nonoxidative process; i.e., lactate
producing) (Figure 1A).
In the mid-1980s, an important series of PET studies conduct-
ed by Fox and Raichle challenged this assumption, and led to
a major breakthrough in our understanding of the mechanisms
underlying task-induced increases in glucose metabolism. In
awake adult humans, they observed that the activity-dependent
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Figure 1. Brain Glucose Utilization
(A) Schematic representation of glucosemetabolism. Glucose enters cells trough glucose transporters (GLUTs) and is phosphorylated byHK to produce glucose-
6-phosphate (glucose-6P). Glucose-6P can be processed into threemainmetabolic pathways. First, it can bemetabolized through glycolysis (i), giving rise to two
molecules of pyruvate and producing ATP and NADH. Pyruvate can then enter mitochondria, where it is metabolized through the tricarboxylic acid (TCA) cycle
and oxidative phosphorylation (Ox Phos), producing ATP and CO2 while consuming oxygen. Pyruvate can otherwise be reduced to lactate by lactate dehy-
drogenase (LDH). This lactate can be released in the extracellular space through monocarboxylate transporters (MCTs). The complete oxidation of glucose
produces larger amounts of energy in the form of ATP in the mitochondria (30–34 ATP) compared to glycolysis (2 ATP). Alternatively, glucose-6P can be pro-
cessed through the pentose phosphate pathway (PPP) (ii), leading to the production of reducing equivalent in the form of NADPH. Note that the PPP and
glycolysis are linked at the level of glyceraldehyde-3-phosphate (GA3P) and fructose-6-phosphate (fructose-6P). Finally, in astrocytes, glucose-6P can also be
used to store glucosyl units as glycogen (iii). Abbreviations are as follows: GPI, glucose-6-phosphate isomerase; PFK, phosphofructokinase-1; Fructose-1,6-P2,
fructose-1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; TPI, triose phosphate isomerase; G6PDH, glucose-6-phosphate dehydrogenase; 6-PGL,
6-phosphoglucono-d-lactone; 6-PG, 6-phosphogluconate; 6 PGDH, 6-phosphogluconate dehydrogenase; ribulose-5P, ribulose-5-phosphate; ribose-5P,
ribose-5-phosphate; xylulose-5P, xylulose-5-phosphate; TK, transketolase; sedoheptulose-7P, sedoheptulose-7-phosphate; TA, transaldolase; and erythrose-
4P, erythrose-4-phosphate.
(B) Differential regulation of CBF, CMRO2, and CMRglc during brain activation in human. Stimulation of the human visual cortex was performed experimentally by
presenting a visual stimulus in the form of a reversing annular chequerboard (i), and determination of CBF, CMRO2, and CMRglc was obtained by PET (ii). When
compared with viewing a blank screen, visual stimulation produces marked changes in activity in visual areas of the brain, as shown in PET images using
pseudocolors (from small increase, blue, to major increase, red). Increases in both blood flow and glucose use in the visual cortex could be observed which are
unaccompanied by similar increases in oxygen use, suggesting that the metabolic needs associated with brain activation are in part met by anaerobic glycolysis.
As a result, the local oxygen availability increases because the increased supply of oxygen by flowing blood exceeds the increased local demand for oxygen.
Such effect accounts for the blood-oxygen-level-dependent (BOLD) signal of fMRI. Reproduced with permission from Gusnard and Raichle (2001).
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Review(visual or somatosensory) increases in blood flow and glucose
utilization were only marginally matched by parallel increases
in oxygen consumption (Fox and Raichle, 1986; Fox et al.,
1988) (Figure 1B). Such uncoupling between CBF and CMRO2
created the rationale for developing blood oxygenation level-
dependent (BOLD) fMRI contrast (Ogawa et al., 1992; Magistretti
and Pellerin, 1996; Raichle and Mintun, 2006). These funda-
mental observations also brought support to the notion that
the metabolic needs of active neural tissue are met, at least
partially, by nonoxidative glucose metabolism (i.e., glycolysis).
This hypothesis was then further supported by various 1H
nuclear magnetic resonance studies showing activity-depen-
dent increases in lactate levels in different brain areas (Figley
and Stroman, 2011, and references therein), giving empirical
demonstration that glycolytic metabolism increases with corre-
sponding elevations in brain activity. It is now generally accepted
that following transient changes in neural activity, (1) blood
delivery increases with metabolic demand, (2) CBF and CMRglcincrease more than oxygen utilization, and (3) both oxidative and
nonoxidative processes are involved to meet the increased
metabolic requirements (Figley and Stroman, 2011).
These observations raised fundamental questions as to the
molecular and cellular mechanisms that could reconcile the
coexistence of increases in oxidative and nonoxidative glucose
metabolism during synaptic activity. Specifically, the open
questions were as follows: are the changes of glucose meta-
bolism (oxidative versus glycolytic) taking place in different cell
compartments; and to which precise cellular processes are
they linked? The evidence pointing at a major contribution of
astrocytes to neuroenergetics (Magistretti et al., 1981; Pellerin
and Magistretti, 1994) has provided a key to the understanding
of these questions.
Cytoarchitectural Organization of the Brain
Astrocytes outnumber neurons in the human brain (Nedergaard
et al., 2003). They play a key role in numerous functions of theCell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 725
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Figure 2. Role of Astrocytes in
Neurovascular Coupling
(A) Morphological features of astrocytes. (i)
Astrocytic endfeet are in close contact with blood
vessels and almost entirely cover their surface
(glial fibrillary acidic protein [GFAP] immunostain-
ing [white] in the rat brain). Scale bar, 50 mm. Re-
produced with permission from Kacem et al.
(1998). (ii) Single astrocytes occupy virtually
distinct territories and enwrap different parts of the
dendritic arborization of a single neuron. Recon-
struction showing a biocytin-filled cortical neuron
(red) and EGFP-expressing cortical astrocytes
(green) in a mouse brain slice. Reproduced with
permission from Halassa et al. (2007). (iii) As-
trocytic processes (in blue, marked by an asterisk)
closely ensheathing a synapse as revealed by
electronic microscopy of mouse brain tissue (S,
spine; and B, bouton). Scale bar, 0.5 mm. Repro-
duced with permission from Genoud et al. (2006).
(iv) 3D reconstruction of a single astroglial process
(blue) interdigitating among many dendrites (four
are shown in gold, yellow, red, and purple) in the
rat hippocampus. Reproduced with permission
from Witcher et al. (2007).
(B) Photolysis of caged Ca2+ in astrocytic endfeet
triggers vasodilation. Time series images of the
cross-section of a penetrating artery in mouse
brain in vivo. Astrocytes were loaded with the Ca2+
indicator dye rhod-2 AM (red) and with DMNP-
EDTA AM, whereas the vasculature was stained
with FITC-dextran (green). Ca2+ uncaging (DMNP-
EDTA photolysis) triggered a rapid increase of
Ca2+ in the astrocytic endfoot associated with
a transient arterial vasodilation (basal arterial
diameter is delineated by a white dashed line). The
arrow indicates the position of photostimulation.
Scale bar, 10 mm. Reproduced with permission
from Takano et al. (2006).
(C) Schematic representation of the main path-
ways by which astrocytes regulate CBF. Neuronal
activity-dependent glutamate release raises
[Ca2+]i in astrocytes by activating metabotropic
glutamate receptors (mGluR). Ca2+ transients in
astrocytes activate cytosolic phospholipase A2
(PLA2), thus producing arachidonic acid (AA). AA
can generate different types of vasodilating
metabolites in astrocytes such as prostaglandins,
in particular PGE2 (via cyclooxygenases) and ep-
oxyeicosatrienoic acids (EETs) (by P450 epox-
ygenases). In parallel, AA can diffuse to arteriolar
smooth muscle cells, where it is converted to 20-
hydroxyeicosatetraenoic acid (20-HETE) by u-
hydroxylase, which has a vasoconstricting effect.
Low [O2], as observed during brain activation,
promotes vasodilation through the increase of
extracellular lactate and adenosine concentra-
tions. Indeed, lactate favors PGE2 accumulation in
the extracellular space and thus vasodilation by
decreasing the efficacy of the prostaglandin
transporter (PGT) in astrocytes, whereas adenosine has an inhibitory effect on 20-HETE-mediated arteriolar constriction. These specific mechanisms as well as
complementary ones involving astrocytes and/or other cell types are reviewed in detail elsewhere (Iadecola and Nedergaard, 2007; Carmignoto and Gomez-
Gonzalo, 2010; Attwell et al., 2010).
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homeostasis, defense against oxidative stress, energy storage
in the form of glycogen, scar formation, tissue repair, modulation
of synaptic activity via the release of gliotransmitters, and
synapse formation and remodeling (Belanger and Magistretti,
2009; Volterra and Meldolesi, 2005). Astrocytes possess unique
cytoarchitectural and phenotypic features that ideally position
them to sense their surroundings and dynamically respond to
changes in their microenvironment. They extend two different726 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.types of processes: fine perisynaptic processes that ensheath
most synapses, and vascular processes (endfeet) that are larger
in diameter and closely apposed onto intraparenchymal blood
vessels (Figure 2A). Perisynaptic processes express a wide
range of receptors for neurotransmitters, cytokines, and growth
factors, as well as various transporters and ion channels. Among
these, receptors and transporters for glutamate are of particular
interest, since they may act as ‘‘sensors’’ of neuronal gluta-
matergic neurotransmission (as discussed below). Astrocytic
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(Iadecola and Nedergaard, 2007; Kacem et al., 1998; Oberheim
et al., 2009). Endfeet express several proteins at their luminal
surface, including glucose transporters and aquaporin 4
(Iadecola and Nedergaard, 2007). Interestingly, human astro-
cytes have been shown to present more complex morphological
and functional features than their rodent counterparts (Oberheim
et al., 2009), which suggests a phylogenetic evolution of astro-
cytic complexity. For example, human neocortical astrocytes
are 2.6 times larger and extend 10 times more processes than
mouse astrocytes (Oberheim et al., 2009).
One striking aspect of glial biology is that astrocytes are terri-
torial cells: fine astrocytic processes ‘‘cover’’ a defined territory
with little overlap between neighboring astrocytes (Oberheim
et al., 2009; Halassa et al., 2007) (Figure 2A), thereby forming
highly organized anatomical domains which are interconnected
into functional networks via gap junctions (Giaume et al.,
2010). It has been demonstrated that a single mature rodent
astrocyte in the gray matter associates with 300–600 neuronal
processes (dendrites) (Halassa et al., 2007) and contacts an esti-
mated 20,000–120,000 synapses (up to 2,000,000 in humans)
(Oberheim et al., 2006, 2009).
Role of Astrocyte-Neuron Interactions in the Regulation
of Cerebral Blood Flow
The morphological and phenotypical characteristics of astro-
cytes are thus tailored to ideally position them (among other
important astrocytic functions) to sense neuronal activity at the
synapse and respond with the appropriate metabolic supply
via their astrocytic endfeet, which enwrap the intracerebral
blood vessels. In line with this, an increasing body of evidence
suggests that astrocytes play a key role in neurovascular
coupling, or in other words, the spatiotemporal coupling
between neuronal activity and increased CBF (also known as
functional hyperemia).
Despite intense research, the exact physiological mechanisms
underlying functional hyperemia are still incompletely under-
stood. Over the past several decades, a variety of vasoactive
agents, including H+, K+, neurotransmitters, adenosine, arachi-
donic acid metabolites, and nitric oxide (NO), released from
different cellular compartments (i.e., neurons, astrocytes, peri-
cytes, and smooth muscle cells), have been implicated in the
activity-dependent increase in CBF (Iadecola and Nedergaard,
2007; Gordon et al., 2008; Carmignoto and Gomez-Gonzalo,
2010; Attwell et al., 2010). Nevertheless, there is now strong
in vitro and in vivo evidence indicating that astrocytes (mainly
through neuron-to-astrocyte and glutamate signaling) are essen-
tial contributors to vasomotor responses, participating in both
vasoconstriction and vasodilation (Carmignoto and Gomez-
Gonzalo, 2010; Attwell et al., 2010; Iadecola and Nedergaard,
2007; Takano et al., 2006). Interestingly, these opposite effects
on the vascular tone were shown to involve different but parallel
signaling cascades in astrocytes. Indeed, Ca2+ transients in
astrocytes resulting from mGluR activation activate cytosolic
phospholipase A2, triggering the formation of arachidonic acid
which is converted into vasodilating agents such as epoxyeico-
satrienoic acids (EETs) and prostaglandin E2 (PGE2) (Zonta et al.,
2003; Takano et al., 2006; Attwell et al., 2010) (Figures 2B and
2C). Alternatively, arachidonic acid can diffuse in smooth musclecells and cause vasoconstriction after its conversion in
20-hydroxyeicosatetraenoic acid (20-HETE) (Mulligan and
MacVicar, 2004; Metea and Newman, 2006) (Figure 2C). Inter-
estingly, Gordon and collaborators demonstrated in rat brain
slices that the balance between vasoconstriction and vasodila-
tion may be dictated by brain metabolism. They observed
that neuronal activation leads to arteriolar dilatation under low-
oxygen conditions, whereas in high-oxygen conditions the
same stimulus induces the constriction of arterioles (Gordon
et al., 2008). The authors also demonstrated that increased
astrocytic activity—reflected by increased astrocytic Ca2+
concentrations—led to the activation of glycolysis and an eleva-
tion of extracellular lactate and adenosine concentrations,
particularly during lower-oxygen conditions. They further eluci-
dated the underlying mechanisms by showing that high external
lactate hinders PGE2 clearance (by attenuating the efficacy of
the prostaglandin transporter), thus increasing extracellular
PGE2, which induces arteriolar dilatation (Figure 2C). In addition,
adenosine released under low oxygen inhibits astrocyte-medi-
ated vasoconstrictions at the level of smooth muscle cells by
blocking the effect of arachidonic acid (Figure 2C).
Although theywere obtained in specific conditions (i.e., ex vivo
preparations with oxygen tensions that are high compared to the
ones measured in vivo) and remain to be confirmed in more
physiological conditions, these observations suggest that under
resting conditions when oxygen is not being rapidly consumed,
astrocytic Ca2+ signals would induce a constricting tone,
keeping CBF at an appropriate lower level. On the opposite,
during activation, the drop in pO2 due to oxygen consumption
(Ances et al., 2001; Offenhauser et al., 2005) and the rise in extra-
cellular lactate and adenosine would promote astrocyte-medi-
ated vasodilation. In support of this, it was recently observed
that increased blood flow to focally active brain regions is highly
correlated with elevations in lactate concentrations but nega-
tively correlated with CMRO2, further suggesting that increased
CBF is driven by glycolytic, as opposed to oxidative, metabolism
under normal physiological conditions (Lin et al., 2010). Overall,
astrocytes now appear as important players in the neurovascular
unit, acting as intermediaries in neuronal signaling to blood
vessels. This in turn firmly supports the notion that astrocytes
are important actors of functional neuroimaging signals in rela-
tion to synaptic activity (Magistretti and Pellerin, 1996; Figley
and Stroman, 2011).
Metabolic Specialization of Neurons and Glia
While the brain is a high energy-consuming organ, it contains
little energy reserves and is therefore highly dependent upon
the uninterrupted supply of energy substrates from the circula-
tion. Impairment in this process results in perturbation of neuro-
logical functions, loss of consciousness, and coma within
minutes. As already mentioned, brain cells can efficiently utilize
various energy substrates in addition to glucose, including
lactate, pyruvate, glutamate, and glutamine (Zielke et al.,
2009). Most of these metabolites are formed endogenously
using glucose as the source of carbon, and—because cerebral
metabolism is a compartmentalized process—complex intercel-
lular trafficking of these metabolites occurs within the brain.
Among these substrates, lactate has been the center of much
attention in recent years. Lactate is present in the extracellularCell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 727
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and 1.5 mM), and while it has long been considered a metabolic
dead end, this view has drastically changed in light of the growing
evidence indicating that it represents an important energy source
for the brain (Schurr et al., 1999; Gallagher et al., 2009; Smith
et al., 2003; Boumezbeur et al., 2010b). Interestingly, emerging
evidence suggests that the end product of glycolysis is lactate
(rather than pyruvate) (Schurr and Payne, 2007). In line with this,
the existence of a putative mitochondrial lactate oxidation
complex has been reported in neuronswhich would allow lactate
entry and oxidation in the mitochondria (Hashimoto et al., 2008).
Importantly, both astrocytes and neurons have the capacity to
fully oxidize glucose and/or lactate (Zielke et al., 2009), which is
in accordance with the observation that both cell type processes
contain equivalent numbers of mitochondria (Lovatt et al., 2007).
However, as will be described in the following sections, neurons
and astrocytes preferentially use different metabolic pathways in
physiological conditions, which is in part due to cell type-specific
expression patterns of key genes regulating energy metabolism
(Lovatt et al., 2007; Herrero-Mendez et al., 2009; Vilchez et al.,
2007). As a result, neurons and astrocytes present different
(but complementary) metabolic profiles, paving the way for
extensive metabolic cooperativity.
Metabolic Profile of Neurons
Neurons Rely on Oxidative Metabolism to Meet Their
High Energy Needs
Consistent with their higher energy requirements, neurons
sustain a high rate of oxidativemetabolismcompared toglial cells
(Lebon et al., 2002; Itoh et al., 2003; Bouzier-Sore et al., 2006;
Boumezbeur et al., 2010a). Interestingly, a largebodyof evidence
shows that neurons can efficiently use lactate as an energy
substrate (Schurr et al., 1997; Bouzier et al., 2000; Qu et al.,
2000; Serres et al., 2005; Boumezbeur et al., 2010b) and even
show a preference for lactate over glucosewhen both substrates
are present (Itoh et al., 2003; Bouzier-Sore et al., 2006).
Recent evidence provides insights into the mechanisms
underlying these neuronal features. Indeed, it has been reported
that the enzyme 6-phosphofructose-2-kinase/fructose-2,6-
bisphosphatase-3 (Pfkfb3) is virtually absent in neurons, due to
its constant proteasomal degradation, which is in stark contrast
with the high expression levels observed in astrocytes (Almeida
et al., 2004; Herrero-Mendez et al., 2009). This enzyme is
responsible for the generation of fructose-2,6-bisphosphate
(fructose-2,6-P2), a potent activator of the glycolytic enzyme
phosphofructokinase-1 (PFK). As a result of a low production
of fructose-2,6-P2, neurons display a slower glycolytic rate
and, unlike astrocytes, are unable to upregulate this pathway
in response to NO-induced cellular stress (Almeida et al., 2004;
Herrero-Mendez et al., 2009). Remarkably, the activation of
neuronal glycolysis via Pfkfb3 overexpression leads to oxidative
stress and apoptosis (Herrero-Mendez et al., 2009), suggesting
that neurons cannot afford to sustain a high glycolytic rate. The
authors showed that the increase in glucose flux via the glyco-
lytic pathway occurs at the expense of metabolism through the
PPP—which is essential for the production of NADPH and there-
fore for the maintenance of the cellular antioxidant potential (see
below). While the exact contribution of the pentose phosphate
and glycolytic pathways to neuronal glucose consumption728 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.remains to be directly established in normal conditions both
in vitro and in vivo, it appears that a fine balance between the
glycolytic pathway and the PPP has to be maintained in neurons
in order to meet their energy needs while maintaining their anti-
oxidant potential—both aspects being essential for their survival.
Consistent with this, the use of lactate as an oxidative substrate
may provide a convenient means for neurons to produce high
amounts of ATP while circumventing the glycolytic pathway,
thereby sparing glucose for the PPP (Bolanos et al., 2010).
Metabolic Profile of Astrocytes
Astrocytes Are Highly Glycolytic
Although astrocytes display lower rates of oxidative metabolism
compared to neurons, they avidly take up glucose and charac-
teristically present a high glycolytic rate (Itoh et al., 2003; Her-
rero-Mendez et al., 2009; Bittner et al., 2010). A large portion
of the glucose entering the glycolytic pathway in astrocytes is
released as lactate in the extracellular space (Itoh et al., 2003;
Bouzier-Sore et al., 2006; Lovatt et al., 2007; Pellerin and Magis-
tretti, 1994; Serres et al., 2005). The glycolytic nature of astro-
cytes and their preference for the production and release of
lactate over the entry of pyruvate in the tricarboxylic acid (TCA)
cycle are the result of a specific gene expression profile which
involves several enzymes and transporters acting in concert to
produce this phenotype.
For instance, the substantial expression level of Pfkfb3 in
astrocytes favors a high glycolytic rate via the allosteric activa-
tion of PFK by fructose-2,6-P2. Another feature of astrocytes,
at the mitochondrial level, is the low expression levels of the
aspartate/glutamate carrier (AGC), a component of the malate-
aspartate shuttle which operates the transfer of reducing equiv-
alents (i.e., NADH) from the cytosol to the mitochondria (Berkich
et al., 2007; Ramos et al., 2003). In this context, the conversion of
glycolytically derived pyruvate to lactate in the cytosol provides
a means by which to ensure the maintenance of a high NAD+/
NADH ratio, which is essential to sustain a high glycolytic rate
(Figure 1A). Finally, the conversion of pyruvate to lactate in astro-
cytes may also be favored by low expression levels (Laughton
et al., 2007) and/or phosphorylation-mediated inactivation (Itoh
et al., 2003; Halim et al., 2010) of pyruvate dehydrogenase,
a key enzyme regulating the entry of pyruvate in the TCA cycle.
Astrocytes Play a Key Role in Neurotransmitter
Recycling and Anaplerosis
One of the best-characterized functions of astrocytes is the rapid
removal of neurotransmitters released into the synaptic cleft, an
essential process for the termination of synaptic transmission
and maintenance of neuronal excitability. This is especially crit-
ical for glutamate, the primary excitatory neurotransmitter in
the brain, as overstimulation of glutamate receptors is highly
toxic to neurons (a phenomenon referred to as excitotoxicity).
Glutamate uptake is primarily achieved by the astrocyte-specific
sodium-dependent high-affinity glutamate transporters gluta-
mate transporter 1 (GLT-1) and glutamate aspartate trans-
porter (GLAST) (corresponding to human EAAT2 and EAAT1,
respectively) (Bak et al., 2006). Following glutamate uptake via
these transporters, astrocytes also play an important role in
transferring this neurotransmitter back to neurons, which is
important to maintain the neuronal neurotransmitter pool of
glutamate. This transfer is achieved by a process called the
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Figure 3. Astrocyte-Neuron Metabolic Interactions
(A) Schematic representation of the astrocyte-neuron lactate shuttle (ANLS).
Glutamate (Glu) released at the synapse activates glutamatergic receptors
(GluR) and is associated with important energy expenditures in neuronal
compartments. A large proportion of the glutamate released at the synapse is
taken up by astrocytes via excitatory amino acid transporters (EAATs, more
specifically GLT-1 and GLAST) together with 3 Na+ ions. This Na+ is extruded
by the action of the Na+/K+ ATPase, consuming ATP. This triggers non-
oxidative glucose utilization in astrocytes and glucose uptake from the
circulation through the glucose transporter GLUT1 expressed by both capil-
lary endothelial cells and astrocytes. Glycolytically derived pyruvate is
converted to lactate by lactate dehydrogenase 5 (LDH5; mainly expressed in
astrocytes) and shuttled to neurons through monocarboxylate transporters
(mainly MCT1 and MCT4 in astrocytes and MCT2 in neurons). In neurons,
this lactate can be used as an energy substrate following its conversion to
pyruvate (Pyr) by LDH1 (mainly expressed in neurons). Neurons can also
take up glucose via the neuronal glucose transporter 3 (GLUT3). Concomi-
tantly, astrocytes participate in the recycling of synaptic glutamate via
the glutamate-glutamine cycle. Following its uptake by astrocytes, glutamate
is converted to glutamine (gln) by the action of glutamine synthetase (GS)
and shuttled to neurons, where it is converted back to glutamate by gluta-
minases (GLS).
(B) Glial glutamate transporters play a central role in neurometabolic coupling.
Glucose utilization (as assessed by the 2-deoxyglucose [2-DG] uptake tech-
nique) was measured in the somatosensory cortex of P10 GLASTmutant mice
following unilateral whisker stimulation. Representative pseudocolored digi-
tized autoradiograms of anteroposterior coronal sections at the level of the
somatosensory barrel field are shown. Whisker stimulation in GLAST+/+ mice
produced a local increase in glucose utilization in the activated somatosensory
cortex (i, white square). Such an increase in glucose utilization was not
observed in coronal sections from GLAST/ mice (ii, white square). Similar
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(Figure 3A). In short, glutamate is converted to glutamine by
the astrocyte-specific enzyme glutamine synthetase. Glutamine
is then transferred to neurons and converted back to glutamate
via deamination by phosphate-activated glutaminase. It is
important to note that glutamate can also be metabolized in
a number of different pathways in astrocytes and neurons,
including oxidation in the TCA cycle (McKenna, 2007). Astro-
cytes are responsible for the replenishment of brain glutamate,
as they are the only neural cell type expressing pyruvate carbox-
ylase, a key enzyme in the main anaplerotic pathway in the brain,
effectively allowing them to synthesize glutamate from glucose
(Magistretti, 2008).
The marked differences in the metabolic profile of astrocytes
and neurons strongly support the notion that brain energy
metabolism must be, at least to a certain extent, a compartmen-
talized process. Importantly, the metabolic phenotypes of these
two cell types appear to be largely complementary.
The Astrocyte-Neuron Lactate Shuttle
Astrocytes are generally considered to account for only
5%–15% of the brain’s energy expenditure (Attwell and Laugh-
lin, 2001; Magistretti, 2008). Recent evidence suggesting that
the energetic cost of action potentials is lower that previously
proposed (Alle et al., 2009) leaves open the possibility that the
contribution of astrocytes to the overall brain energetic costs
may have been underestimated. Nevertheless, experimental
evidence demonstrates that the amount of glucose that astro-
cytes actually take up is disproportionally high in comparison
to their energy requirements. For example, in acute cerebellar
slices, the uptake of fluorescent glucose analogs is several-
fold higher in Bergmann glia than in Purkinje cells (Barros et al.,
2009). In the resting rat brain, other studies have shown that
astrocytes are responsible for approximately half of glucose
uptake (Nehlig et al., 2004; Chuquet et al., 2010), and that this
proportion increases even further upon functional activation
(Chuquet et al., 2010).
How can these data be reconciled with the fact that neurons—
not astrocytes—have the highest energy needs? The transfer of
energy substrates from astrocytes to neurons could provide
a simple explanation for this apparent paradox. This is a central
point of the astrocyte-neuron lactate shuttle (ANLS) model
proposed over a decade ago by Pellerin and Magistretti (Fig-
ure 3A) (Pellerin andMagistretti, 1994). The essence of thismodelresults were obtained in GLT-1 mutant mice. Reproduced with permission
from Voutsinos-Porche et al. (2003).
(C) Astrocytes play an important role in glutathione metabolism in the brain.
The tripeptide glutathione (GSH) is synthetized by the successive actions of
glutamate cysteine ligase (GCL) and GSH synthetase. Astrocytes can effi-
ciently use oxidized cysteine (cystine) for GSH synthesis. Astrocytes release
a large amount of GSH in the extracellular space, where it is cleaved by the
astrocytic ectoenzyme g-glutamyl transpeptidase (gGT). The resulting
dipeptide CysGly is cleaved by the neuronal ectopeptidase aminopeptidase N
(ApN), forming cysteine (Cys) and glycine (Gly), which serve as precursors for
neuronal GSH synthesis. GSH is an electron donor in many reactions in both
neurons and astrocytes, including the detoxification of ROS (e.g., the reduc-
tion of peroxides [ROOH] by glutathione peroxidase [GPx]). The oxidized
glutathione (GSSG) formed as a result is recycled back to glutathione by the
action of glutathione reductase (GR) using NADPH as an electron donor. X
represents an acceptor for the g-glutamyl moiety (gGlu) in the reaction cata-
lyzed by gGT.
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glutamatergic neurotransmission), which is avidly taken up via a
Na+-dependent mechanism by specific glial glutamate trans-
porters; (2) the resulting increase in [Na+]i activates the Na
+/K+
ATPase (in particular by mobilizing its alpha2 subunit), thereby
increasing ATP consumption (Magistretti and Chatton, 2005),
glucose uptake, and glycolysis in astrocytes; (3) this in turn leads
to a large increase in the production of lactate which is released
in the extracellular space; and (4) lactate can be used as an
energy substrate for neurons for oxidative-derived ATP produc-
tion (for review, see Pellerin et al., 2007; Magistretti, 2009).
The concept of a lactate shuttle—which was first introduced
by Brooks, who described the transfer of lactate between glyco-
lytic and oxidative muscle fibers as early as the mid-1980s—has
now been extended to several other biological systems and
includes intracellular lactate shuttles, cell-cell lactate shuttles,
and interorgan lactate shuttles (see Brooks, 2009 for review). In
brain cells, early experimental evidence suggesting a role of
astrocytes in coupling glutamatergic transmission and energy
metabolism via a lactate shuttle was obtained in vitro by Pellerin
and Magistretti (1994), who have shown that glutamate uptake
into astrocytes increases glucose utilization and lactate release
from these cells. The stimulation of astrocytic glucose utilization
by glutamate was subsequently confirmed by several indepen-
dent groups (reviewed in Pellerin et al., 2007; Barros and
Deitmer, 2010). Evidence that such a mechanism also occurs
in vivo during functional brain activation was provided by the
demonstration that reduced expression of astrocyte-specific
glutamate transporters strongly impairs the activity-dependent
increase in glucose utilization (Cholet et al., 2001; Voutsinos-
Porche et al., 2003; Herard et al., 2005) (Figure 3B). More
recently, a real-time two-photon microscopy study has shown
that the fluorescent glucose analog 6-[N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl) amino]-2-deoxy-D-glucose (6-NBDG) is prefer-
entially taken up in astrocytes rather than in neurons in the rat
barrel cortex following whisker stimulation (Chuquet et al., 2010).
Interestingly, following exposure to glutamate in mixed
cultured cells, the stimulation of glucose utilization in astrocytes
is concomitant with a rapid inhibition of glucose transport in
neurons, which is more pronounced in the presence of lactate
(Porras et al., 2004). In other words, following glutamatergic
activity, there is a shift of glucose utilization away from neurons
and toward astrocytes, suggesting that an energy substrate
other than glucose must be used by neurons to meet the
increased energy requirements associated with activation.
According to the redox switch hypothesis (Cerdan et al., 2006),
the inhibition of glucose transport (and consequently of glycol-
ysis) induced by glutamate in neurons would create thermo-
dynamically favorable conditions for the use of lactate as an
energy substrate in this cell type, since these two processes
compete for intracellular NAD+ (Figure 1A).
Using hippocampal slice preparations, it has been possible to
obtain some evidence for a spatial and temporal compartmenta-
tion of energy metabolism, by monitoring changes in NADH
levels by means of two-photon microscopy. In these prepara-
tions, activation of the intrahippocampal Schaffer collateral
pathway induced a biphasic NADH fluorescence responsewhich
consisted of a rapid and transient decrease of NADH levels in
neuronal dendrites, reaching a minimum 10 s after stimulation,730 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.followed by a sustained overshoot of NADH levels in astrocytic
processes, peaking at 60 s (Kasischke et al., 2004). These obser-
vations suggest that, following stimulation, the rapid activation of
oxidative metabolism in neurons causes a decrease in NADH
levels, which rapidly recovers following the activation of the
TCA cycle; in contrast, astrocytes display a delayed but sus-
tained increase of their glycolytic rate (Kasischke et al., 2004).
Although their study did not identify the substrates used by
neurons to produce NADH, it is interesting to note that the
sequence of events observed by Kasischke and collaborators
closely parallels the temporal changes in extracellular lactate
levels observed in vivo, i.e., a transient decrease in extracellular
lactate levels after stimulation both in the human and rodent brain
(Hu and Wilson, 1997; Mangia et al., 2003) followed by a sus-
tained increase in extracellular lactate (Prichard et al., 1991; Hu
and Wilson, 1997; Lin et al., 2010). Together, these studies
suggest that as a result of neuronal activation, extracellular
lactate is rapidly oxidized by neurons tomeet their energy needs,
a process closely followed by a sustained activation of the glyco-
lytic pathway in astrocytes, allowing for the replenishment of the
extracellular lactate pool. It should be mentioned, however, that
a recent report using two-photon imaging in vivo was unable to
demonstrate similar cell-specific changes of NADH intensity in
the cortex of mice following focal activation (Kasischke et al.,
2011). Further studies are warranted to clarify this issue.
Additional support for the shuttling of lactate from astrocytes
to neurons and its use by the latter as an energy substrate was
recently provided by an elegant study by Rouach and collabora-
tors (2008). Results of this study demonstrated that during
glucose deprivation—which resulted in a 50% depression of
synaptic transmission in hippocampal slices—glucose delivery
into a single astrocyte and its subsequent diffusion through the
astrocytic syncitium could rescue neuronal activity. This effect
was mimicked by lactate but was abolished in the presence of
the monocarboxylate transporter (MCT) inhibitor a-cyano-4-
hydroxycinnamic acid, suggesting that glucose present in the
astrocytic network is metabolized to lactate, transported out of
astrocytes, and used by neurons to sustain their synaptic activity
(Rouach et al., 2008).
Interestingly, it has also been demonstrated in primary
cultured astrocytes that electrical or mechanical stimulation trig-
gers ‘‘metabolic waves,’’ in addition to the well-described Ca2+
waves that travel through the astrocytic network (Bernardinelli
et al., 2004). These metabolic waves are mediated by the
Ca2+-dependent release of glutamate, which in turn triggers
a Na+ wave in the astrocytic network resulting from glutamate
uptake via Na+-dependent glutamate transporters. Remarkably,
the propagating Na+ signal is spatially and temporally correlated
with an increase in glucose uptake, which is also dependent on
the activity of astrocytic glutamate transporters. Such metabolic
waves could mediate the propagation of the metabolic response
within the astrocytic network away from the site of activation,
allowing for a concerted neurometabolic coupling within the
activated area (Bernardinelli et al., 2004).
By coupling glucose utilization (via astrocyte glycolysis) to
neuronal activity and oxidative phosphorylation, the ANLS is
consistent with previous studies that have implicated a nonoxi-
dative metabolic component during focal brain activation (see
the Introduction and Fox et al., 1988). Moreover, these data
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mainly reflect glucose consumption in astrocytes rather than in
neurons (Magistretti and Pellerin, 1996; Chuquet et al., 2010; Fig-
ley and Stroman, 2011). This in turn raises important questions
about the interpretation of PET data showing modifications of
glucose consumption, as observed in Alzheimer’s disease
patients, for example (e.g., should it be attributed to a neuronal
or an astrocytic component, or both) (Mosconi et al., 2008).
It is important to note, however, that the ANLS does not
exclude the possibility that some of the energy needs of the brain
are met by the astrocytic TCA cycle and by the glycolytic
pathway in neurons. In this regard, it should be mentioned that
there are still divergent point of views concerning some aspects
of the ANLS (Simpson et al., 2007; Mangia et al., 2009; DiNuzzo
et al., 2010; Chih and Roberts, 2003). In particular, based mainly
on modeling studies, some reports suggest a higher glucose
transport capacity in neurons compared to astrocytes (DiNuzzo
et al., 2010; Mangia et al., 2009; Simpson et al., 2007). From this
prediction, neurons were considered to be mainly (if not exclu-
sively) dependent on glucose uptake, as opposed to astrocytic
lactate delivery, to fuel their energy needs in both resting and
activating states. This theoretical conclusion based on modeling
studies is, however, inconsistent with the observation that mice
presenting a haploinsufficiency of the neuron-specific glucose
transporter GLUT3 do not present any neurological or brain
energy metabolism abnormalities. Furthermore, their brain glu-
cose utilization is not different from wild-type animals (Schmidt
et al., 2008; Stuart et al., 2011). In contrast, haploinsufficiency
forGLUT1, which is absent in neurons, results in a severe neuro-
logical phenotype (Wang et al., 2006). A further critical discus-
sion about the ANLS has been presented in Jolivet et al. (2010).
Overall, a considerable body of evidence supports the notion
of a net transfer of energy from astrocytes to neurons in the
form of lactate as a result of glutamatergic transmission, as
proposed by the ANLS.
Astrocytic Glycogen Metabolism
Despite its relatively low level in the CNS compared to peripheral
tissues, glycogen is the largest energy reserve of the brain. It
represents an advantageous form of glucose storage, as it can
be rapidly metabolized without requirements for ATP, and unlike
fatty acids it can yield ATP under anaerobic conditions. Interest-
ingly, at the cellular level, glycogen has been found to be almost
exclusively localized in astrocytes in the adult brain (Magistretti
et al., 1993; Brown, 2004). Although neurons express the enzy-
matic machinery for synthesizing glycogen (i.e., glycogen syn-
thase) both in vitro and in vivo (Brown, 2004; Vilchez et al.,
2007), recent evidence shows that this machinery is kept inactive
in neurons through proteasomal-dependent mechanisms
(Vilchez et al., 2007). More surprisingly, manipulations that drive
glycogendeposition inculturedneuronscauseapoptosis (Vilchez
et al., 2007), further demonstrating that glycogen constitutes
a specific feature of astrocytic glucose metabolism. The
restrictedcellular localizationof glycogen raisesanobviousques-
tion: why is the main energy reserve of the brain found in astro-
cytes instead of neurons, which are the most energy-requiring
neural cell type? This suggests that glycogen metabolism may
involve metabolic interactions between astrocytes and neurons.
A first set of evidences was presented in the early 1980s by thedemonstration that a restricted set of neurotransmitters, i.e.,
neuronal-derived molecules, could promote glycogenolysis in
cortical slices and primary astrocyte cultures (Magistretti et al.,
1981, 1983). Furthermore, studies showing that increasing astro-
cytic glycogen stores preserves neuronal function and viability in
conditions of limited energy availability, such as hypoglycemia,
provided additional evidence for neuron-glia metabolic coupling
involving glycogen (Brown and Ransom, 2007; Brown, 2004;
and references therein). While glycogen mobilization may also
fulfill the astrocytes’ own metabolic needs (Sickmann et al.,
2009; Walls et al., 2009), glycogen breakdown typically results
in lactate production and release in the extracellular space (Walls
et al., 2009; Dringen et al., 1993). Considering the role of astro-
cytic glucose-derived lactate in fuelling neuronal energy needs
(described above in the ANLS section), this positions lactate as
a likely candidate to account for the protective effects of
glycogen. In support of this, axonal function was demonstrated
to be preserved during aglycemia through the transfer of
glycogen-derived lactate from astrocytes to axons in an optic
nerve preparation (Tekkok et al., 2005; Brown et al., 2005).
In addition to its role as an emergency energy reserve, there is
compelling evidence indicating other important roles for
glycogen in normal brain functions. A physiological role of brain
glycogenwas first suggested on the basis of the following obser-
vations: (1) glycogen content is under the dynamic control of
neurotransmitters (e.g., noradrenaline, serotonin, and vasoactive
intestinal peptide [VIP]), neurohumoral agents (e.g., insulin), and
local energy status (e.g., glucose levels) (Magistretti et al.,
1981, 1993; Brown, 2004); (2) decreased neuronal activity, as
observed during sleep and anesthesia, correlates with increased
levels of brain glycogen, consistentwith the notion that theawake
brain utilizes glycogen (Magistretti et al., 1993; Brown, 2004); and
(3) increased neuronal activity induced by sensory stimulation is
associated with a decrease in glycogen levels in the activated
areas, demonstrating a tight coupling between neuronal activity
and glycogen mobilization (Swanson et al., 1992; Dienel et al.,
2007). It was also demonstrated that astrocytic glycogen mobili-
zation (likely associated with the transfer of lactate from astro-
cytes to neurons) is required to sustain neuronal activity during
intense stimulation in a mouse optic nerve preparation (Brown
et al., 2005; Tekkok et al., 2005) and to maintain glutamatergic
synaptic transmission (i.e., neurotransmitter release) in coculture
models (Sickmann et al., 2009; Mozrzymas et al., 2011).
A demonstration of the implication of glycogen metabolism
in higher brain functions was first obtained by Gibbs and collab-
orators, who demonstrated that pharmacological inhibition of
glycogenolysis in astrocytes (using 1,4-dideoxy-1,4-imino-D-
arabinitol [DAB], a potent inhibitor of glycogen phosphorylase)
interrupts memory consolidation in young chickens in a bead
discrimination learning task (Gibbs et al., 2006). Very recently,
the involvement of astrocytic glycogen-derived lactate in long-
term memory formation, and for the in vivo maintenance of
long-term potentiation (LTP) of synaptic strength in the mamma-
lian brain, was demonstrated by Suzuki and colleagues (Suzuki
et al., 2011). In this study, it was observed that intrahippocampal
injection of DAB specifically impairs long-term memory forma-
tion (while leaving unaffected short-termmemory) in an inhibitory
avoidance test in rats (Figure 4A). Among other evidence, it was
shown that this effect can be rescued by the addition ofCell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 731
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Figure 4. Mobilization of the Astrocytic Glycogen Stores Is Necessary for Long-Term Memory Formation in Rats
(A) Summary of the main findings reported by Suzuki et al. (2011). Rows represent individual experiments, and columns indicate treatments and results obtained.
Prior to inhibitory avoidance training, rats received intrahippocampal injections of 1,4-dideoxy-1,4-imino-D-arabinitol (DAB, a potent inhibitor of glycogen
phosphorylase), lactate, or antisense oligodeoxynucleotides, as indicated. Short-term memory (STM) was assessed 1 hr later (experiment 1), while long-term
memory (LTM) formation was assessed after 1 and 7 days (experiments 2–7). Results and conclusion are given for each individual experiment. Note that
monocarboxylate transporter (MCT)-1 knockdown produced similar results to those obtained with MCT4 knockdown (experiments 4 and 5).
(B) Schematic representation of the cellular mechanisms involving glycogen mobilization in long-term memory formation. Synaptic activity associated with
a learning task (1) triggers astrocytic glycogen breakdown (2) and the release of lactate viaMCT1 andMCT4 (3) in rat hippocampus. Lactate is taken up by neurons
via MCT2 (4) and triggers an increase in the expression of the activity-dependent gene Arc as well as the phosphorylation of CREB (a nuclear transcription factor)
and cofilin (an actin-binding protein) (5), which are all known to contribute to memory consolidation processes. These events are likely involved in the structural
synaptic changes necessary for the establishment of long-term memory (6). The mechanisms by which lactate causes these effects are yet to be determined
(indicated by question marks).
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expression of the main neuronal lactate transporter (MCT2)
was disrupted using antisense oligodeoxynucleotides, demon-732 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.strating the importance of glycogen-derived lactate transport
into neurons for memory consolidation (Figure 4A). Interestingly,
glycogenolysis and astrocytic lactate transporters were also
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required for memory formation, including the induction of phos-
pho-cAMP response element-binding (CREB), activity-regulated
cytoskeletal-associated protein (Arc), and phospho-cofilin (Su-
zuki et al., 2011), suggesting that lactate may also act as
a signaling molecule in this context (Figure 4B).
As a whole, these observations demonstrate that astrocytic
glycogen is more than a simple emergency reserve, and plays
an important and active role in complex brain physiological func-
tions, in particular through an astrocyte-to-neuron transfer of
energy metabolites in the form of lactate. It thus appears that
both glucose- and glycogen-derived lactate are important to
sustain neuronal function, as postulated by the ANLS.
The Role of Astrocyte-Neuron Interactions
for the Defense against Oxidative Stress
The brain is particularly susceptible to oxidative damage. This
is illustrated by the fact that oxidative injury is a key feature of
several neuropatholological conditions such as stroke, traumatic
brain injury, and neurodegenerative diseases (including Alz-
heimer’s disease, Parkinson’s disease, Huntington’s disease,
and amyotrophic lateral sclerosis) (Wilson, 1997; Dringen,
2000). Several factors contribute to increased brain vulnerability
to oxidative stress, including its high rate of oxidative energy
metabolism (a process inevitably generating reactive oxygen
species, ROS, as a byproduct), its high unsaturated fatty acids
content (which are prone to lipid peroxidation), and its relatively
low intrinsic antioxidant capacity (Dringen, 2000). Paradoxically,
despite the fact that the greater part of the brain’s oxidative
metabolism occurs in neurons, this cell type displays limited
defensemechanismsagainst oxidative stresscompared toastro-
cytes. Indeed, astrocytes have significantly higher levels of
various antioxidant molecules and ROS-detoxifying enzymes,
including glutathione, heme-oxygenase 1, glutatione peroxidase,
glutathione S-transferase, catalase, and thioredoxin reductase
(Shih et al., 2003; Dringen, 2000; Belanger and Magistretti,
2009; Wilson, 1997). The greater antioxidant potential of astro-
cytes is further evidenced by the fact that they are much more
resistant than neurons to cellular damage induced by pro-oxidant
compoundssuchasH2O2,NO,peroxinitrites, and6-hydroxydop-
amine (Wilson, 1997; Dringen, 2000; Almeida et al., 2001). Impor-
tantly, in coculture systems, astrocytes also protect neighboring
neurons from toxic doses of NO, H2O2, superoxide anion
combined with NO, iron, or 6-hydroxydopamine (Wilson, 1997;
Vargas and Johnson, 2009; Dringen, 2000; Belanger and Magis-
tretti, 2009), suggesting that neurons are dependent upon the
high antioxidant potential of astrocytes for their own defense
against oxidative stress.
The shuttling of glutathione (GSH) precursors from astrocytes
to neurons appears to be instrumental in the neuroprotective
effects of astrocytes (Figure 3C). GSH—the most abundant anti-
oxidant molecule in the brain—acts either directly as a ROS
scavenger or can be used as a substrate for glutathione S-trans-
ferase or glutathione peroxidase (Dringen, 2000). Both neurons
and astrocytes can synthesize the GSH tripeptide (g-L-glutamyl-
L-cysteinylglycine); however, neurons are highly dependent on
astrocytes for the supply of the precursor amino acids necessary
for their own GSH synthesis. This is especially crucial for
cysteine, the rate-limiting substrate for GSH synthesis, sinceneurons, unlike astrocytes, have a poor capacity to use extra-
cellular cystine (the oxidized form of cysteine) as a precursor
(Dringen, 2000). Cultured astrocytes release large amounts of
GSH into the extracellular space—up to 10% of their total
content within 1 hr (Dringen, 2000). GSH is then cleaved by the
astrocytic ectoenzyme g-glutamyl transpeptidase (gGT) to
produce CysGly, which in turn is cleaved by the extracellular
neuronal aminopeptidase N, producing glycine and cysteine
readily available to neurons for their own GSH synthesis
(Dringen, 2000). As a result of this shuttling process, the GSH
content of neurons is strongly increased when they are cultured
in the presence of astrocytes (Dringen, 2000). In contrast, GSH-
depleted astrocytes display a reduced ability to protect neurons
against oxidative injury, highlighting the importance of this coop-
erative mechanism for neuronal defense against oxidative stress
(Chen et al., 2001; Shih et al., 2003). The differential antioxidant
response of neurons and astrocytes is in part explained by the
preferential astrocytic expression and activation of the nuclear
factor erythroid-2-related factor 2 (Nrf2), a redox-sensitive tran-
scription factor playing a key role in orchestrating the cellular
antioxidant response (Vargas and Johnson, 2009).
Relationship between Antioxidant DefenseMechanisms
and Energy Metabolism
The reduction of peroxides catalyzed by glutathione peroxidase
generates glutathione disulfide (GSSG, the oxidized form of
GSH). GSH can subsequently be regenerated from GSSG by
the action of the enzyme glutathione reductase, using NADPH
as an electron donor (Dringen, 2000). This process is essential
for the maintenance of GSH in its reduced form, and thus for
its availability for the detoxification of ROS. As a consequence,
constant NADPH supply is essential for the maintenance of the
cellular redox state. NADPH production is mainly achieved by
the metabolism of glucose via the PPP, thereby coupling gluta-
thione recycling to glucose utilization. Interestingly, it has been
demonstrated that NADPH is more abundant in astrocytes
than in neurons, and that astrocytes have a higher basal PPP
activity rate and a better capacity to stimulate this pathway in
response to oxidative stress (Garcia-Nogales et al., 2003; Ben
Yoseph et al., 1996). Consistent with this, transcriptome analysis
in astrocytes and neurons freshly isolated from the mouse brain
also reveal higher expression levels of glucose-6-phosphate
dehydrogenase, the rate-limiting enzyme of the PPP, in astro-
cytes compared to neurons (Lovatt et al., 2007; Cahoy et al.,
2008). These features also contribute to the higher antioxidant
potential of astrocytes.
An ascorbic acid metabolic switch has been proposed as
another level of interaction between antioxidant mechanisms
and neuroenergetic pathways (Castro et al., 2009). According
to this model, astrocytes release the antioxidant molecule
ascorbic acid in response to glutamatergic activity. This ascorbic
acid is taken up by neurons and modifies local energy metabo-
lism by inhibiting glucose consumption and increasing lactate
uptake (Castro et al., 2009). Thus, in addition to contributing to
the antioxidant capacity of neurons, ascorbic acid shuttling
may provide another mechanism by which neuronal lactate
utilization is favored (over glucose) in order to meet the energy
needs associated with glutamatergic activation (as proposed
by the ANLS).Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 733
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A large body of experimental evidence suggests that astrocytes
have a greater metabolic plasticity than neurons, i.e., they can
better adapt their energy metabolism to face various cellular chal-
lenges. A striking example is the differential response of astrocytes
and neurons following the inhibition of mitochondrial respiration
induced by NO. Astrocytes respond to NO with an increase in
glucose metabolism through the glycolytic pathway, thereby
limiting the fall in ATP levels and preventing apoptosis. In neurons,
however, this response does not seem to be present, and a similar
NO challenge causes a massive ATP depletion, leading to
apoptosis (Almeida et al., 2001). Another strong indication of the
limitedmetabolicplasticityofneurons isprovidedbyrecent studies
which have shown that driving a higher glycolytic rate (Herrero-
Mendez et al., 2009) or glycogen synthesis (Vilchez et al., 2007)
in neurons causes apoptotic cell death, even though these path-
ways are generally innocuous (or even beneficial) in astrocytes.
While the metabolic plasticity of astrocytes is an important
feature for their homeostatic and neuroprotective functions in
physiological conditions, it may become a double-edged sword
in pathological conditions. Indeed, considering the extensive
functional cooperativity taking place between neurons and
astrocytes, any significant alteration of astrocytic pathways
caused by pathological stimuli could potentially contribute to
neuronal dysfunction. In support of this, our group has reported
that the internalization by astrocytes of amyloid-beta (Ab), a
peptide associated with Alzheimer’s disease, induces profound
changes in their metabolic phenotype, in terms of both energy
metabolism and oxidative status. Exposure of naive neurons to
these ‘‘Ab-filled’’ astrocytes resulted in neuronal cell death
(Allaman et al., 2010). The contribution of astrocytic dysfunction
to neurodegenerative processes is currently under intense
investigation, and a rapidly growing body of evidence indicates
that enhancing or reestablishing astrocytic functions may repre-
sent promising therapeutic avenues for neurodegenerative
disease (see Allaman et al., 2011, for review).
Astrocyte-Neuron Energetic Interactions Influence
Neuronal Excitability
Astrocytes are known to modulate synaptic transmission by the
Ca2+-dependent release of neuroactive molecules (called glio-
transmitters) such as glutamate, D-serine, ATP, or adenosine.
Description of these mechanisms is beyond the scope of this
article, but they have been reviewed by several authors (see,
e.g., Volterra and Meldolesi, 2005). In addition to this, there are
now strong evidences demonstrating that astrocyte-neuron
interactions at the energy metabolism level (in particular through
lactate release by astrocytes) also influence higher brain func-
tions (Ainscow et al., 2002; Lam et al., 2005; Shimizu et al.,
2007; Erlichman et al., 2008; Parsons and Hirasawa, 2010;
Suzuki et al., 2011). We have already described the role of
astrocytic glycogen breakdown and associated lactate release
for long-term memory formation (Suzuki et al., 2011). Here we
will provide additional examples illustrating the role of astro-
cyte-derived lactate in controlling neuronal activity.
(1) Glucose-sensing neurons within satiety and feeding
centers of the hypothalamus increase their firing rate in response
to elevation of central glucose levels, ultimately resulting in734 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.decreased blood glucose and insulin levels and the suppression
of hepatic gluconeogenesis (Lam et al., 2005, 2009). This central
regulation of glucose homeostasis can be recapitulated by intra-
cerebroventricular lactate infusions, showing that these neurons
also function as ‘‘lactate sensors’’ (Lam et al., 2005, 2009). More
importantly, the regulation of hypothalamic ‘‘glucose-sensing’’
neuron activity has been shown to implicate lactate trafficking
between astrocytes and neurons (Lam et al., 2005, 2009).
(2) Orexin neurons also function as lactate sensors (Parsons
and Hirasawa, 2010). In hypothalamic slice preparations, the
firing rate of orexin neurons is specifically regulated by astro-
cyte-derived lactate. Even in the presence of glucose, lactate
disinhibits and sensitizes orexin neurons, priming them for
subsequent excitation (Parsons and Hirasawa, 2010). These
observations highlight lactate as an important regulator of the
orexin system, which is known to participate in the control of
arousal and feeding behavior (Tsujino and Sakurai, 2009).
(3) The firing rate activity of g-aminobutyric acid (GABA)-ergic
neurons of the subfornical organ (SFO), which control salt-intake
behavior, is also influenced by extracellular astrocyte-derived
lactate (Shimizu et al., 2007) (Figure 5A). This process involves
Na+ sensing by astrocytes and ependymal cells via specific
Na+ channels, which in turn activate the Na+/K+ ATPase pump.
This results in increased glycolysis and concomitant lactate
release into the extracellular space and activation of inhibitory
GABAergic neurons (Shimizu et al., 2007).
Interestingly, the underlying mechanisms for the effects of
lactate on neuronal excitability in the three examples described
above (glucose-sensing, orexin, and SFO GABAergic neurons)
appear to critically involve ATP-sensitive K+ channels (KATP)
(Ainscow et al., 2002; Lam et al., 2005; Shimizu et al., 2007;
Parsons and Hirasawa, 2010). These channels close with
increased ATP levels, a process that suppresses the efflux of
K+ ions, leading to depolarization of the plasma membrane,
and the firing of action potentials (Tarasov et al., 2004). Thus,
increased free cytosolic ATP concentration, derived from lactate
oxidation, triggers the closure of KATP channels leading to
neuronal activation, providing a mechanism that links lactate
release by astrocytes, lactate utilization by neurons, and modu-
lation of neuronal excitability (Figure 5B). Other regulatory
processes of neuronal excitability by lactate shuttling between
astrocytes and neurons may also operate. For example, a pH-
dependent effect of lactate has been reported to modulate the
activity of the chemosensory (pH-dependent) neurons of the ret-
rotrapezoid nucleus in the ventral medulla which control the
breathing rate (Erlichman et al., 2008).
Conclusions
Overall the observations presented in this review demonstrate
that brain energy metabolism involves more complex cellular
and molecular mechanisms than previously thought. The field
of neuroenergetics has evolved from a neurocentric view into
a more integrated one in which complementarities and coopera-
tivities between astrocytes and neurons play a central role. A
striking demonstration is the coordination of both the CBF
response (neurovascular coupling) and the stimulation of meta-
bolism (neurometabolic coupling), which are necessary to meet
the increased energy requirements of active neurons and
astrocytes during brain activation. In addition to this, metabolic
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Figure 5. Glial-Released Lactate Can Control Neuronal Activity
(A) Control by lactate of salt-intake behavior by the subfornical organ (SFO). In
the SFO, specific Na+ channels (Nax) populate perineural processes of
astrocytes and ependymal cells (facing the third ventricle). When animals are
dehydrated, Na+ concentration in plasma and the cerebrospinal fluid increases
above the usual level (1). This leads to Nax channels opening in ependymal and
glial cells (2), resulting in the increase in intracellular Na+ concentration and the
activation of Na+/K+ ATPase (3). To fuel Na+/K+ ATPase with ATP, glucose
uptake and glycolysis are enhanced (4) consistently with the ANLS model.
Lactate is released and supplied to neurons, including GABAergic neurons (5).
Lactate stimulates the activity of the GABAergic neurons through the
production of ATP (see below), which presumably regulates neurons involved
in the control of salt-intake behavior (6). Ependymal cells are depicted in this
figure for simplicity; however, the same scheme is applicable for intra-
parenchymal Nax-positive astrocytes. Reproduced with permission from
Shimizu et al. (2007).
(B) Proposed mechanism by which lactate can contribute to the control of
neuronal activity. Stimulation of glucose utilization in astrocytes results in the
increase of extracellular lactate levels. Lactate is taken up by neurons, where it
is oxidized in themitochondria, thus increasing neuronal ATP levels. This leads
to an increased [ATP]/[ADP] ratio and the closure of the KATP channels, thus
promoting membrane depolarization and neuronal electrical activity.
Cell Metabolism
Reviewinteractions—in particular in the form of lactate shuttling from
astrocytes to neurons—appear to play an important role in the
control of neuronal activity and excitability.
Although these observations open novel perspectives for the
understanding of neuroenergetics, some critical questions
remain at the moment unresolved. Are these metabolic interac-
tions relevant for all brain structures, and do they generally apply
to all conditions? Are other neural cell types, such as oligoden-drocytes, actively participating in these processes? Another
intriguing question concerns the fundamental functional benefits
afforded by the metabolic compartmentation between astro-
cytes and neurons as opposed to an ‘‘every cell for itself’’ use
of energy substrate(s). In line with this, there is now evidence
that these neuroenergetic interactions are not only dedicated
to fuelling energy-demanding cells but also act as signaling
events participating in the control of important brain functions
such as whole-body homeostasis or memory consolidation.
The importance of neuron-astrocyte metabolic interactions is
illustrated by a large body of evidence indicating that distur-
bances in these processes contribute to neurodegenerative
disorders. Accordingly, new therapeutic avenues aimed at
preserving or enhancing astrocytic function in order to harness
their intrinsic neuroprotective properties are beginning to be
envisioned and will certainly attract further attention from the
pharma and biotech world.
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